TapewireFind a company

person · Reporting owner

KOSKI ROBERT C

Disclosed activity across 3 companies

Tapewire entity
71583
SEC CIK
0001234880

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
LKA GOLD Inc /DE/LKAI · Entity 16650110% ownerNovember 20, 2017January 26, 2018
ORAGENICS INCOGEN · Entity 8495DirectorDecember 11, 2025December 15, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

LKA GOLD Inc /DE/

Report date November 20, 2017 · Filed January 26, 2018

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
common stockSEC Table I · non-derivativeDirect2,171,400 Ending reported balance After 2018-01-26 transaction · row 10
10 source rows · reconciled sequence

Row 1 · 2017-11-20 · Purchase · Acquired 6,000 · Balance 2,071,700

Row 2 · 2017-11-21 · Purchase · Acquired 5,000 · Balance 2,076,700

Row 3 · 2017-11-22 · Purchase · Acquired 5,100 · Balance 2,081,800

Row 4 · 2017-11-24 · Purchase · Acquired 2,000 · Balance 2,083,800

Row 5 · 2017-11-27 · Purchase · Acquired 9,000 · Balance 2,092,800

Row 6 · 2017-11-28 · Purchase · Acquired 6,400 · Balance 2,099,200

Row 7 · 2017-11-29 · Purchase · Acquired 22,000 · Balance 2,121,200

Row 8 · 2017-11-30 · Purchase · Acquired 10,200 · Balance 2,131,400

Row 9 · 2018-01-23 · Purchase · Acquired 20,000 · Balance 2,151,400

Row 10 · 2018-01-26 · Purchase · Acquired 20,000 · Balance 2,171,400

ORAGENICS INC

Report date December 11, 2025 · Filed December 15, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Non-Employee Director Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.93 · Expires 2035-12-11Direct125,000 Reported balance After 2025-12-11 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2025-12-11 · Grant · Acquired 125,000 · Balance 125,000

F1: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

Filing footnotes · ownership attribution and instrument terms

F1: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

HELIOS TECHNOLOGIES, INC.

Report date August 09, 2019 · Filed August 09, 2019

Section 16 reporting ended · disclosed 2019-08-09. Current position is not established by this disclosure.

No balance rows disclosed in this filing.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
December 11, 2025 Filed Dec 15, 2025 21:19 UTC ORAGENICS INC OGEN · Entity 8495 GrantNon-Employee Director Option (Right to Buy) · Derivative 125,000 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0001234880-25-000002 · primary_doc.xml · derivative · entry 1

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2035-12-11

F1 · security: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · shares: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · balance_after: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

Read SEC document
December 11, 2024 Filed Dec 13, 2024 21:05 UTC ORAGENICS INC OGEN · Entity 8495 ConversionSeries B Convertible Preferred Stock · Derivative 1,500,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-24-049989 · ownership.xml · derivative · entry 3

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Series B was convertible into common stock at any time and had no expiration date. The Series B was issued on November 8, 2017, with an original issue price of $0.50 per share. On January 19, 2018, the Issuer effected a 1-for-10 reverse stock split, and on January 20, 2023, the Issuer effected a one-for-sixty reverse stock split, which collectively resulted in an adjusted conversion price of $300.00 per share.

F3 · price: The Series B was convertible into common stock at any time and had no expiration date. The Series B was issued on November 8, 2017, with an original issue price of $0.50 per share. On January 19, 2018, the Issuer effected a 1-for-10 reverse stock split, and on January 20, 2023, the Issuer effected a one-for-sixty reverse stock split, which collectively resulted in an adjusted conversion price of $300.00 per share.

F3 · derivative.exercise_date: The Series B was convertible into common stock at any time and had no expiration date. The Series B was issued on November 8, 2017, with an original issue price of $0.50 per share. On January 19, 2018, the Issuer effected a 1-for-10 reverse stock split, and on January 20, 2023, the Issuer effected a one-for-sixty reverse stock split, which collectively resulted in an adjusted conversion price of $300.00 per share.

F3 · derivative.expiration_date: The Series B was convertible into common stock at any time and had no expiration date. The Series B was issued on November 8, 2017, with an original issue price of $0.50 per share. On January 19, 2018, the Issuer effected a 1-for-10 reverse stock split, and on January 20, 2023, the Issuer effected a one-for-sixty reverse stock split, which collectively resulted in an adjusted conversion price of $300.00 per share.

F2 · derivative.underlying_shares: Represents the full conversion of Series B Convertible Preferred Stock ("Series B") held by the KFLP into shares of common stock, pursuant to, and in accordance with, the certificate of designation for the Series B.

F1 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

Read SEC document
December 11, 2024 Filed Dec 13, 2024 21:05 UTC ORAGENICS INC OGEN · Entity 8495 ConversionCommon Stock 5,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-24-049989 · ownership.xml · nonDerivative · entry 2

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 23,367

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

F2 · shares: Represents the full conversion of Series B Convertible Preferred Stock ("Series B") held by the KFLP into shares of common stock, pursuant to, and in accordance with, the certificate of designation for the Series B.

F1 · price: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

F2 · price: Represents the full conversion of Series B Convertible Preferred Stock ("Series B") held by the KFLP into shares of common stock, pursuant to, and in accordance with, the certificate of designation for the Series B.

F3 · price: The Series B was convertible into common stock at any time and had no expiration date. The Series B was issued on November 8, 2017, with an original issue price of $0.50 per share. On January 19, 2018, the Issuer effected a 1-for-10 reverse stock split, and on January 20, 2023, the Issuer effected a one-for-sixty reverse stock split, which collectively resulted in an adjusted conversion price of $300.00 per share.

F1 · balance_after: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

F2 · balance_after: Represents the full conversion of Series B Convertible Preferred Stock ("Series B") held by the KFLP into shares of common stock, pursuant to, and in accordance with, the certificate of designation for the Series B.

F1 · ownership.direct: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

F2 · ownership.direct: Represents the full conversion of Series B Convertible Preferred Stock ("Series B") held by the KFLP into shares of common stock, pursuant to, and in accordance with, the certificate of designation for the Series B.

F1 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

F2 · ownership.nature: Represents the full conversion of Series B Convertible Preferred Stock ("Series B") held by the KFLP into shares of common stock, pursuant to, and in accordance with, the certificate of designation for the Series B.

Read SEC document
September 19, 2024 Filed Sep 21, 2024 01:15 UTC ORAGENICS INC OGEN · Entity 8495 GrantNon-Employee Director Option (Right to Buy) · Derivative 65,000 $0.00 Strike: $0.48 $0.00
Disclosure

SEC source: 0001493152-24-037731 · ownership.xml · derivative · entry 1

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,000

Underlying: Common Stock · 65,000 shares

Expires 2034-09-19

F1 · security: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · shares: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · derivative.exercise_date: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · balance_after: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

Read SEC document
August 08, 2023 Filed Aug 10, 2023 20:30 UTC ORAGENICS INC OGEN · Entity 8495 GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-027579 · ownership.xml · nonDerivative · entry 1

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,689

F1 · shares: Represents an award of restricted stock pursuant to the Company's non-employee director compensation program under the Company's 2021 Equity Incentive Plan with 20,000 shares vesting immediately and 5,000 shares vesting in six (6) months.

F2 · balance_after: Reflects adjustments made in connection with the 1-for-60 reverse stock split of the Issuer's common stock which became effective on January 23, 2023.

Read SEC document
August 08, 2023 Filed Jan 22, 2024 22:30 UTC ORAGENICS INC OGEN · Entity 8495 GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-003332 · ownership.xml · nonDerivative · entry 1

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,940

F1 · balance_after: This Form 5 is being filed by the Reporting Person to correct an administrative error, which incorrectly reported the number of shares of Common Stock as beneficially owned by the Reporting Person.

Read SEC document
December 30, 2022 Filed Jan 3, 2023 21:20 UTC ORAGENICS INC OGEN · Entity 8495 SaleCommon Stock 42,357 $0.11 $4,468.66
Disclosure

SEC source: 0001493152-23-000130 · ownership.xml · nonDerivative · entry 2

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,102,295

F1 · price: The prices reported in Column 4 were the weighted average prices on the Transaction Dates indicated. The shares were sold in multiple transactions ranging from $0.1020 to $0.1121 and $0.1026 to $0.1096 on each Transaction Date, respectively. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F3 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

Read SEC document
December 29, 2022 Filed Jan 3, 2023 21:20 UTC ORAGENICS INC OGEN · Entity 8495 SaleCommon Stock 36,648 $0.11 $3,884.69
Disclosure

SEC source: 0001493152-23-000130 · ownership.xml · nonDerivative · entry 1

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 176,191

F1 · price: The prices reported in Column 4 were the weighted average prices on the Transaction Dates indicated. The shares were sold in multiple transactions ranging from $0.1020 to $0.1121 and $0.1026 to $0.1096 on each Transaction Date, respectively. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F2 · ownership.direct: Shares owned directly by Robert C. Koski, a director of the Company.

Read SEC document
December 15, 2022 Filed Dec 16, 2022 21:05 UTC ORAGENICS INC OGEN · Entity 8495 SaleCommon Stock 140,497 $0.18 $24,699.37
Disclosure

SEC source: 0001493152-22-035732 · ownership.xml · nonDerivative · entry 2

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,144,652

F1 · price: The prices reported in Column 4 were the weighted average prices on the Transaction Dates indicated. The shares were sold in multiple transactions ranging from $0.1700 to $0.1800 and $0.1600 to $0.1800 on each Transaction Date, respectively. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F2 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

Read SEC document
December 14, 2022 Filed Dec 15, 2022 21:15 UTC ORAGENICS INC OGEN · Entity 8495 SaleCommon Stock 4,503 $0.18 $788.03
Disclosure

SEC source: 0001493152-22-035570 · ownership.xml · nonDerivative · entry 1

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,310,149

F1 · price: The price reported in Column 4 was the weighted average price on the Transaction Date indicated. The shares were sold in multiple transactions ranging from $0.1700 to $0.1800 on the Transaction Date. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F2 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

Read SEC document
December 14, 2022 Filed Dec 16, 2022 21:05 UTC ORAGENICS INC OGEN · Entity 8495 SaleCommon Stock 25,000 $0.18 $4,375.00
Disclosure

SEC source: 0001493152-22-035732 · ownership.xml · nonDerivative · entry 1

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,285,149

F1 · price: The prices reported in Column 4 were the weighted average prices on the Transaction Dates indicated. The shares were sold in multiple transactions ranging from $0.1700 to $0.1800 and $0.1600 to $0.1800 on each Transaction Date, respectively. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F2 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

Read SEC document
December 09, 2022 Filed Dec 12, 2022 21:22 UTC ORAGENICS INC OGEN · Entity 8495 SaleCommon Stock 48,795 $0.20 $9,612.62
Disclosure

SEC source: 0001493152-22-035184 · ownership.xml · nonDerivative · entry 1

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,314,652

F1 · price: The price reported in Column 4 was the weighted average price on the Transaction Date indicated. The shares were sold in multiple transactions ranging from $0.1750 to $0.2000 on the Transaction Date. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F2 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

Read SEC document
December 08, 2022 Filed Dec 9, 2022 21:14 UTC ORAGENICS INC OGEN · Entity 8495 SaleCommon Stock 13,036 $0.20 $2,607.20
Disclosure

SEC source: 0001493152-22-035043 · ownership.xml · nonDerivative · entry 1

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,363,447

F1 · price: The prices reported in Column 4 are weighted average prices on the Transaction Date indicated. The shares were sold in multiple transactions ranging from $0.1901 to $0.2000 on the Transaction Date. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F2 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

Read SEC document
November 30, 2022 Filed Dec 1, 2022 21:08 UTC ORAGENICS INC OGEN · Entity 8495 SaleCommon Stock 200,000 $0.19 $38,220.00
Disclosure

SEC source: 0001493152-22-034167 · ownership.xml · nonDerivative · entry 2

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,376,483

F1 · price: The prices reported in Column 4 are weighted average prices on the Transaction Dates indicated. The shares were sold in multiple transactions ranging from $0.1900 to $0.2100 and $0.1800 to $0.2000 on each Transaction Date, respectively. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F2 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

Read SEC document
November 29, 2022 Filed Dec 1, 2022 21:08 UTC ORAGENICS INC OGEN · Entity 8495 SaleCommon Stock 200,000 $0.19 $38,460.00
Disclosure

SEC source: 0001493152-22-034167 · ownership.xml · nonDerivative · entry 1

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,576,483

F1 · price: The prices reported in Column 4 are weighted average prices on the Transaction Dates indicated. The shares were sold in multiple transactions ranging from $0.1900 to $0.2100 and $0.1800 to $0.2000 on each Transaction Date, respectively. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F2 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

Read SEC document
July 29, 2022 Filed Aug 2, 2022 20:42 UTC ORAGENICS INC OGEN · Entity 8495 GrantNon-Employee Director Option (Right to Buy) · Derivative 220,000 $0.00 Strike: $0.36 $0.00
Disclosure

SEC source: 0001493152-22-021024 · ownership.xml · derivative · entry 1

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 220,000

Underlying: Common Stock · 220,000 shares

Expires 2032-07-29

F1 · security: Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022.

F1 · shares: Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022.

F1 · derivative.underlying_shares: Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022.

F1 · balance_after: Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022.

Read SEC document
December 31, 2021 Filed Jan 3, 2022 21:29 UTC ORAGENICS INC OGEN · Entity 8495 PurchaseCommon Stock 799,100 $0.47 $378,773.40
Disclosure

SEC source: 0001493152-22-000118 · ownership.xml · nonDerivative · entry 2

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,776,483

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.44 to $0.48.

F3 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

Read SEC document
December 30, 2021 Filed Jan 3, 2022 21:29 UTC ORAGENICS INC OGEN · Entity 8495 PurchaseCommon Stock 200,900 $0.45 $90,364.82
Disclosure

SEC source: 0001493152-22-000118 · ownership.xml · nonDerivative · entry 1

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 977,383

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.43 to $0.46. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

F3 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

Read SEC document
December 16, 2021 Filed Dec 17, 2021 22:09 UTC ORAGENICS INC OGEN · Entity 8495 GrantNon-Employee Director Option (Right to Buy) · Derivative 75,000 $0.00 Strike: $0.49 $0.00
Disclosure

SEC source: 0001493152-21-031893 · ownership.xml · derivative · entry 1

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2031-12-16

F1 · security: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021.

F1 · shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021.

F1 · derivative.underlying_shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021.

F1 · balance_after: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021.

Read SEC document
February 18, 2021 Filed Feb 19, 2021 21:35 UTC ORAGENICS INC OGEN · Entity 8495 GrantNon-Employee Director Option (Right to Buy) · Derivative 160,000 $0.00 Strike: $1.20 $0.00
Disclosure

SEC source: 0001493152-21-004423 · ownership.xml · derivative · entry 4

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,000

Underlying: Common Stock · 160,000 shares

Expires 2031-02-18

F1 · security: Shares owned directly by Robert C. Koski, a director of the Company.

F4 · shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021.

F4 · derivative.underlying_shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021.

F4 · balance_after: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021.

Read SEC document
January 02, 2021 Filed Feb 19, 2021 21:35 UTC ORAGENICS INC OGEN · Entity 8495 GiftCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-21-004423 · ownership.xml · nonDerivative · entry 1

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 212,839

F1 · ownership.direct: Shares owned directly by Robert C. Koski, a director of the Company.

Read SEC document
December 22, 2020 Filed Dec 23, 2020 23:15 UTC ORAGENICS INC OGEN · Entity 8495 SaleCommon Stock 310,000 $0.43 $132,432.00
Disclosure

SEC source: 0001493152-20-024267 · ownership.xml · nonDerivative · entry 2

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 776,483

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F2 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

Read SEC document
April 24, 2020 Filed Dec 23, 2020 23:15 UTC ORAGENICS INC OGEN · Entity 8495 GiftCommon Stock 35,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-20-024267 · ownership.xml · nonDerivative · entry 1

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 242,839

F1 · ownership.direct: Shares owned directly by Robert C. Koski, a director of the Company.

Read SEC document
February 05, 2020 Filed Feb 7, 2020 21:25 UTC ORAGENICS INC OGEN · Entity 8495 GrantNon-Employee Director Option (Right to Buy) · Derivative 156,540 $0.00 Strike: $0.48 $0.00
Disclosure

SEC source: 0001493152-20-001790 · ownership.xml · derivative · entry 2

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,540

Underlying: Common Stock · 156,540 shares

Expires 2030-02-05

F2 · security: Represents a discretionary retention award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's Plan. The options vest on the first anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 5, 2020.

F2 · shares: Represents a discretionary retention award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's Plan. The options vest on the first anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 5, 2020.

F2 · derivative.underlying_shares: Represents a discretionary retention award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's Plan. The options vest on the first anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 5, 2020.

F2 · balance_after: Represents a discretionary retention award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's Plan. The options vest on the first anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 5, 2020.

Read SEC document
February 05, 2020 Filed Feb 7, 2020 21:25 UTC ORAGENICS INC OGEN · Entity 8495 GrantNon-Employee Director Option (Right to Buy) · Derivative 156,540 $0.00 Strike: $0.48 $0.00
Disclosure

SEC source: 0001493152-20-001790 · ownership.xml · derivative · entry 1

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,540

Underlying: Common Stock · 156,540 shares

Expires 2030-02-05

F1 · security: Represents an annual award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended (the "Plan") that vests immediately.

F1 · shares: Represents an annual award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended (the "Plan") that vests immediately.

F1 · derivative.underlying_shares: Represents an annual award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended (the "Plan") that vests immediately.

F1 · balance_after: Represents an annual award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended (the "Plan") that vests immediately.

Read SEC document
December 30, 2019 Filed Dec 31, 2019 21:10 UTC ORAGENICS INC OGEN · Entity 8495 SaleCommon Stock 100,000 $0.53 $52,610.00
Disclosure

SEC source: 0001493152-19-019927 · ownership.xml · nonDerivative · entry 3

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,086,483

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $0.52 to $0.535. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F2 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

Read SEC document
December 27, 2019 Filed Dec 31, 2019 21:10 UTC ORAGENICS INC OGEN · Entity 8495 SaleCommon Stock 100,000 $0.52 $51,670.00
Disclosure

SEC source: 0001493152-19-019927 · ownership.xml · nonDerivative · entry 2

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,186,483

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $0.51 to $0.5239. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F2 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

Read SEC document
July 31, 2019 Filed Aug 2, 2019 20:57 UTC HELIOS TECHNOLOGIES, INC. HLIO · Entity 4399 SaleCommon Stock 3,100 $49.03 $151,995.17
Disclosure

SEC source: 0001234878-19-000006 · primary_doc.xml · nonDerivative · entry 1

KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner

KOSKI BEVERLY · CIK 0001234877 · 10% owner

KOSKI FAMILY LP · CIK 0001234879 · 10% owner

KOSKI THOMAS L · CIK 0001234881 · 10% owner

KOSKI ROBERT C · CIK 0001234880 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,152

F1 · kind: Sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2019.

F2 · price: The range of prices for the transactions reported is $49.00 - $49.1050. The undersigned hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.direct: Shares owned directly by Christine L. Koski.

Read SEC document
July 24, 2019 Filed Jul 25, 2019 18:29 UTC HELIOS TECHNOLOGIES, INC. HLIO · Entity 4399 SaleCommon Stock 5,000 $48.00 $240,022.00
Disclosure

SEC source: 0001234878-19-000005 · primary_doc.xml · nonDerivative · entry 1

KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner

KOSKI BEVERLY · CIK 0001234877 · 10% owner

KOSKI FAMILY LP · CIK 0001234879 · 10% owner

KOSKI THOMAS L · CIK 0001234881 · 10% owner

KOSKI ROBERT C · CIK 0001234880 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,252

F1 · kind: Sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2019.

F2 · price: The range of prices for the transactions reported is $48.00 - $48.0450. The undersigned hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.direct: Shares owned directly by Christine L. Koski.

Read SEC document
June 27, 2019 Filed Jul 2, 2019 00:29 UTC HELIOS TECHNOLOGIES, INC. HLIO · Entity 4399 SaleCommon Stock 2,500 $44.32 $110,800.00
Disclosure

SEC source: 0001234880-19-000007 · primary_doc.xml · nonDerivative · entry 1

KOSKI ROBERT C · CIK 0001234880 · 10% owner

KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner

KOSKI BEVERLY · CIK 0001234877 · 10% owner

KOSKI FAMILY LP · CIK 0001234879 · 10% owner

KOSKI THOMAS L · CIK 0001234881 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,500

F1 · price: The range of prices for the transactions reported is $44.28 - $44.35. The undersigned hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2 · ownership.direct: Shares owned directly by Robert C. Koski.

Read SEC document
June 24, 2019 Filed Jun 26, 2019 23:11 UTC HELIOS TECHNOLOGIES, INC. HLIO · Entity 4399 SaleCommon Stock 2,500 $45.72 $114,300.00
Disclosure

SEC source: 0001234878-19-000004 · primary_doc.xml · nonDerivative · entry 1

KOSKI ROBERT C · CIK 0001234880 · 10% owner

KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner

KOSKI BEVERLY · CIK 0001234877 · 10% owner

KOSKI FAMILY LP · CIK 0001234879 · 10% owner

KOSKI THOMAS L · CIK 0001234881 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

F1 · price: The range of prices for the transactions reported is $45.65 - $45.75. The undersigned hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2 · ownership.direct: Shares owned directly by Robert C. Koski.

Read SEC document
June 21, 2019 Filed Jun 25, 2019 21:13 UTC HELIOS TECHNOLOGIES, INC. HLIO · Entity 4399 SaleCommon Stock 5,000 $47.03 $235,166.00
Disclosure

SEC source: 0001234878-19-000003 · primary_doc.xml · nonDerivative · entry 1

KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner

KOSKI BEVERLY · CIK 0001234877 · 10% owner

KOSKI FAMILY LP · CIK 0001234879 · 10% owner

KOSKI THOMAS L · CIK 0001234881 · 10% owner

KOSKI ROBERT C · CIK 0001234880 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,252

F1 · price: The range of prices for the transactions reported is $47.00 - $47.14. The undersigned hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2 · ownership.direct: Shares owned directly by Christine L. Koski.

Read SEC document
June 20, 2019 Filed Jun 24, 2019 21:06 UTC ORAGENICS INC OGEN · Entity 8495 GrantNon-Employee Director Option (Right to Buy) · Derivative 156,540 Not disclosed Strike: $0.48 Not disclosed
Disclosure

SEC source: 0000899243-19-017959 · doc4.xml · derivative · entry 7

KOSKI ROBERT C · CIK 0001234880 · Director

KOSKI CHRISTINE L · CIK 0001234878 · Affiliate

KOSKI BEVERLY · CIK 0001234877 · Affiliate

KOSKI FAMILY LP · CIK 0001234879 · Affiliate

KOSKI THOMAS L · CIK 0001234881 · Affiliate

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,540

Underlying: Common Stock · 156,540 shares

Expires 2029-06-20

F8 · shares: Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a non-employee director. The option exercise price is the closing price on the date of the grant, June 20, 2019 (the "Grant Date"). The options vest quarterly in even amounts over the four quarters following the Grant Date.

F8 · price: Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a non-employee director. The option exercise price is the closing price on the date of the grant, June 20, 2019 (the "Grant Date"). The options vest quarterly in even amounts over the four quarters following the Grant Date.

F8 · derivative.exercise_date: Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a non-employee director. The option exercise price is the closing price on the date of the grant, June 20, 2019 (the "Grant Date"). The options vest quarterly in even amounts over the four quarters following the Grant Date.

F8 · derivative.underlying_shares: Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a non-employee director. The option exercise price is the closing price on the date of the grant, June 20, 2019 (the "Grant Date"). The options vest quarterly in even amounts over the four quarters following the Grant Date.

F8 · balance_after: Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a non-employee director. The option exercise price is the closing price on the date of the grant, June 20, 2019 (the "Grant Date"). The options vest quarterly in even amounts over the four quarters following the Grant Date.

Read SEC document
June 18, 2019 Filed Jun 20, 2019 15:30 UTC HELIOS TECHNOLOGIES, INC. HLIO · Entity 4399 SaleCommon Stock 2,500 $45.59 $113,976.00
Disclosure

SEC source: 0001234880-19-000006 · primary_doc.xml · nonDerivative · entry 1

KOSKI ROBERT C · CIK 0001234880 · 10% owner

KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner

KOSKI BEVERLY · CIK 0001234877 · 10% owner

KOSKI FAMILY LP · CIK 0001234879 · 10% owner

KOSKI THOMAS L · CIK 0001234881 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,500

F1 · price: The range of prices for the transactions reported is $45.50 - $45.67. The undersigned hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2 · ownership.direct: Shares owned directly by Robert C. Koski.

Read SEC document
June 17, 2019 Filed Jun 18, 2019 18:26 UTC HELIOS TECHNOLOGIES, INC. HLIO · Entity 4399 SaleCommon Stock 6,792 $46.59 $316,416.19
Disclosure

SEC source: 0001234878-19-000002 · primary_doc.xml · nonDerivative · entry 3

KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner

KOSKI BEVERLY · CIK 0001234877 · 10% owner

KOSKI FAMILY LP · CIK 0001234879 · 10% owner

KOSKI THOMAS L · CIK 0001234881 · 10% owner

KOSKI ROBERT C · CIK 0001234880 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,252

F3 · price: The range of prices for the transactions reported is $46.33 - $46.71. The undersigned hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F1 · ownership.direct: Shares owned directly by Christine L. Koski.

Read SEC document
June 17, 2019 Filed Jun 18, 2019 18:26 UTC HELIOS TECHNOLOGIES, INC. HLIO · Entity 4399 SaleCommon Stock 18,908 $45.71 $864,280.90
Disclosure

SEC source: 0001234878-19-000002 · primary_doc.xml · nonDerivative · entry 2

KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner

KOSKI BEVERLY · CIK 0001234877 · 10% owner

KOSKI FAMILY LP · CIK 0001234879 · 10% owner

KOSKI THOMAS L · CIK 0001234881 · 10% owner

KOSKI ROBERT C · CIK 0001234880 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,044

F2 · price: The range of prices for the transactions reported is $45.33 - $46.3250. The undersigned hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F1 · ownership.direct: Shares owned directly by Christine L. Koski.

Read SEC document
June 14, 2019 Filed Jun 17, 2019 18:23 UTC HELIOS TECHNOLOGIES, INC. SNHY · Entity 4399 SaleCommon Stock 4,300 $45.03 $193,630.72
Disclosure

SEC source: 0001234880-19-000005 · primary_doc.xml · nonDerivative · entry 2

KOSKI ROBERT C · CIK 0001234880 · 10% owner

KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner

KOSKI BEVERLY · CIK 0001234877 · 10% owner

KOSKI FAMILY LP · CIK 0001234879 · 10% owner

KOSKI THOMAS L · CIK 0001234881 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,202

F3 · price: The range of prices for the transactions reported is $45.00 - $45.47. The undersigned hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F4 · ownership.direct: Shares owned directly by Christine L. Koski.

Read SEC document
June 14, 2019 Filed Jun 18, 2019 18:26 UTC HELIOS TECHNOLOGIES, INC. HLIO · Entity 4399 GrantCommon Stock 750 $44.73 $33,547.50
Disclosure

SEC source: 0001234878-19-000002 · primary_doc.xml · nonDerivative · entry 1

KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner

KOSKI BEVERLY · CIK 0001234877 · 10% owner

KOSKI FAMILY LP · CIK 0001234879 · 10% owner

KOSKI THOMAS L · CIK 0001234881 · 10% owner

KOSKI ROBERT C · CIK 0001234880 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,952

F1 · ownership.direct: Shares owned directly by Christine L. Koski.

Read SEC document
June 13, 2019 Filed Jun 17, 2019 18:23 UTC HELIOS TECHNOLOGIES, INC. SNHY · Entity 4399 SaleCommon Stock 2,500 $45.12 $112,811.25
Disclosure

SEC source: 0001234880-19-000005 · primary_doc.xml · nonDerivative · entry 1

KOSKI ROBERT C · CIK 0001234880 · 10% owner

KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner

KOSKI BEVERLY · CIK 0001234877 · 10% owner

KOSKI FAMILY LP · CIK 0001234879 · 10% owner

KOSKI THOMAS L · CIK 0001234881 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

F1 · price: The range of prices for the transactions reported is $45.02 - $45.22. The undersigned hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2 · ownership.direct: Shares owned directly by Robert C. Koski.

Read SEC document
June 07, 2019 Filed Jun 11, 2019 16:55 UTC HELIOS TECHNOLOGIES, INC. SNHY · Entity 4399 SaleCommon Stock 2,500 $45.16 $112,892.00
Disclosure

SEC source: 0001234880-19-000004 · primary_doc.xml · nonDerivative · entry 1

KOSKI ROBERT C · CIK 0001234880 · 10% owner

KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner

KOSKI BEVERLY · CIK 0001234877 · 10% owner

KOSKI FAMILY LP · CIK 0001234879 · 10% owner

KOSKI THOMAS L · CIK 0001234881 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,500

F1 · price: The range of prices for the transactions reported is $45.112 - $45.189. The undersigned hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2 · ownership.direct: Shares owned directly by Robert C. Koski.

Read SEC document
March 29, 2019 Filed Apr 2, 2019 16:04 UTC HELIOS TECHNOLOGIES, INC. SNHY · Entity 4399 SaleCommon Stock 10,000 $46.52 $465,241.00
Disclosure

SEC source: 0001234880-19-000003 · primary_doc.xml · nonDerivative · entry 1

KOSKI ROBERT C · CIK 0001234880 · 10% owner

KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner

KOSKI BEVERLY · CIK 0001234877 · 10% owner

KOSKI FAMILY LP · CIK 0001234879 · 10% owner

KOSKI THOMAS L · CIK 0001234881 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

F1 · price: The range of prices for the transactions reported is $46.23 - $46.76. The undersigned hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2 · ownership.direct: Shares owned directly by Robert C. Koski.

Read SEC document
March 08, 2019 Filed Mar 11, 2019 21:09 UTC HELIOS TECHNOLOGIES, INC. SNHY · Entity 4399 GrantCommon Stock 750 $48.59 $36,442.50
Disclosure

SEC source: 0001234878-19-000001 · primary_doc.xml · nonDerivative · entry 1

KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner

KOSKI BEVERLY · CIK 0001234877 · 10% owner

KOSKI FAMILY LP · CIK 0001234879 · 10% owner

KOSKI THOMAS L · CIK 0001234881 · 10% owner

KOSKI ROBERT C · CIK 0001234880 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,502

F1 · ownership.direct: Shares owned directly by Christine L. Koski.

Read SEC document
March 04, 2019 Filed Mar 6, 2019 14:24 UTC HELIOS TECHNOLOGIES, INC. SNHY · Entity 4399 SaleCommon Stock 2,500 $50.15 $125,385.00
Disclosure

SEC source: 0001234880-19-000002 · primary_doc.xml · nonDerivative · entry 2

KOSKI ROBERT C · CIK 0001234880 · 10% owner

KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner

KOSKI BEVERLY · CIK 0001234877 · 10% owner

KOSKI FAMILY LP · CIK 0001234879 · 10% owner

KOSKI THOMAS L · CIK 0001234881 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,000

F2 · price: The range of prices for the transactions reported is $50.00 - $50.36. The undersigned hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F1 · ownership.direct: Shares owned directly by Robert C. Koski.

Read SEC document
March 01, 2019 Filed Mar 6, 2019 14:24 UTC HELIOS TECHNOLOGIES, INC. SNHY · Entity 4399 SaleCommon Stock 2,500 $49.25 $123,125.00
Disclosure

SEC source: 0001234880-19-000002 · primary_doc.xml · nonDerivative · entry 1

KOSKI ROBERT C · CIK 0001234880 · 10% owner

KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner

KOSKI BEVERLY · CIK 0001234877 · 10% owner

KOSKI FAMILY LP · CIK 0001234879 · 10% owner

KOSKI THOMAS L · CIK 0001234881 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,500

F1 · ownership.direct: Shares owned directly by Robert C. Koski.

Read SEC document
December 18, 2018 Filed Dec 20, 2018 16:55 UTC HELIOS TECHNOLOGIES, INC. SNHY · Entity 4399 GrantCommon Stock 750 $36.43 $27,322.50
Disclosure

SEC source: 0001234878-18-000012 · primary_doc.xml · nonDerivative · entry 1

KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner

KOSKI BEVERLY · CIK 0001234877 · 10% owner

KOSKI FAMILY LP · CIK 0001234879 · 10% owner

KOSKI THOMAS L · CIK 0001234881 · 10% owner

KOSKI ROBERT C · CIK 0001234880 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,752

F1 · ownership.direct: Shares owned directly by Christine L. Koski.

Read SEC document
September 27, 2018 Filed Oct 1, 2018 20:07 UTC ORAGENICS INC OGEN · Entity 8495 GrantNon-Employee Director Option (Right to Buy) · Derivative 125,000 $0.00 Strike: $0.73 $0.00
Disclosure

SEC source: 0000899243-18-025660 · doc4.xml · derivative · entry 7

KOSKI FAMILY LP · CIK 0001234879 · 10% owner

KOSKI ROBERT C · CIK 0001234880 · Director · 10% owner

KOSKI THOMAS L · CIK 0001234881 · 10% owner

KOSKI CHRISTINE L · CIK 0001234878 · 10% owner

KOSKI BEVERLY · CIK 0001234877 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2028-09-27

F8 · shares: Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended in connection with service to the Company as a director. The options vest immediately. The option exercise price is the closing price on the date of the grant, September 27, 2018.

F8 · balance_after: Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended in connection with service to the Company as a director. The options vest immediately. The option exercise price is the closing price on the date of the grant, September 27, 2018.

Read SEC document
September 21, 2018 Filed Sep 24, 2018 21:13 UTC HELIOS TECHNOLOGIES, INC. SNHY · Entity 4399 SaleCommon Stock 4,580 $58.03 $265,796.64
Disclosure

SEC source: 0001234878-18-000010 · primary_doc.xml · nonDerivative · entry 4

KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner

KOSKI BEVERLY · CIK 0001234877 · 10% owner

KOSKI FAMILY LP · CIK 0001234879 · 10% owner

KOSKI THOMAS L · CIK 0001234881 · 10% owner

KOSKI ROBERT C · CIK 0001234880 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,252

F1 · kind: Sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2018.

F6 · price: The range of prices for the transactions reported is $58.00 - $58.11. The undersigned hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.direct: Shares owned directly by Christine L. Koski.

Read SEC document
September 21, 2018 Filed Sep 24, 2018 21:13 UTC HELIOS TECHNOLOGIES, INC. SNHY · Entity 4399 SaleCommon Stock 5,900 $57.54 $339,493.08
Disclosure

SEC source: 0001234878-18-000010 · primary_doc.xml · nonDerivative · entry 3

KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner

KOSKI BEVERLY · CIK 0001234877 · 10% owner

KOSKI FAMILY LP · CIK 0001234879 · 10% owner

KOSKI THOMAS L · CIK 0001234881 · 10% owner

KOSKI ROBERT C · CIK 0001234880 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,832

F1 · kind: Sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2018.

F5 · price: The range of prices for the transactions reported is $57.00 - $57.76. The undersigned hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.direct: Shares owned directly by Christine L. Koski.

Read SEC document
September 21, 2018 Filed Sep 25, 2018 19:48 UTC HELIOS TECHNOLOGIES, INC. SNHY · Entity 4399 GrantCommon Stock 750 $57.56 $43,170.00
Disclosure

SEC source: 0001234878-18-000011 · primary_doc.xml · nonDerivative · entry 1

KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner

KOSKI BEVERLY · CIK 0001234877 · 10% owner

KOSKI FAMILY LP · CIK 0001234879 · 10% owner

KOSKI THOMAS L · CIK 0001234881 · 10% owner

KOSKI ROBERT C · CIK 0001234880 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,002

F1 · ownership.direct: Shares owned directly by Christine L. Koski.

Read SEC document
September 20, 2018 Filed Sep 24, 2018 21:13 UTC HELIOS TECHNOLOGIES, INC. SNHY · Entity 4399 SaleCommon Stock 5,970 $56.92 $339,784.94
Disclosure

SEC source: 0001234878-18-000010 · primary_doc.xml · nonDerivative · entry 2

KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner

KOSKI BEVERLY · CIK 0001234877 · 10% owner

KOSKI FAMILY LP · CIK 0001234879 · 10% owner

KOSKI THOMAS L · CIK 0001234881 · 10% owner

KOSKI ROBERT C · CIK 0001234880 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,732

F1 · kind: Sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2018.

F4 · price: The range of prices for the transactions reported is $56.51 - $57.40. The undersigned hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.direct: Shares owned directly by Christine L. Koski.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.